Andreas Reinisch

17PUBLICATIONS
96CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Medical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)Chemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 02, 2026
Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Chloe A L Thompson-Peach, Daniel Thomas, Mara Dottore

|Dec 15, 2025
Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study.

Stefan Hatzl, Christina Geiger, Lisa Kriegl

|Feb 03, 2025
Pulmonary Coinfection of Pneumocystis jirovecii and Aspergillus Species.

Stefan Hatzl, Christina Geiger, Lisa Kriegl

|Nov 11, 2024
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care center.

Sonja Wurm, Michael Waltersdorfer, Simone Loindl

|Feb 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.

Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia

|Nov 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.

Daniel Thomas, Manhong Wu, Yusuke Nakauchi

Pageof 3

Frequent Collaborators

7 joint publications

Armin Zebisch

7 joint publications

Heinz Sill

6 joint publications

Albert Wölfler

6 joint publications

Johannes Foßelteder